97.50
Precedente Chiudi:
$100.95
Aprire:
$101.5
Volume 24 ore:
120.89K
Relative Volume:
0.63
Capitalizzazione di mercato:
$538.68M
Reddito:
$249.13M
Utile/perdita netta:
$6.71M
Rapporto P/E:
80.74
EPS:
1.2076
Flusso di cassa netto:
$39.58M
1 W Prestazione:
-0.45%
1M Prestazione:
+3.23%
6M Prestazione:
+17.95%
1 anno Prestazione:
+31.17%
Mesa Laboratories Inc Stock (MLAB) Company Profile
Nome
Mesa Laboratories Inc
Settore
Industria
Telefono
(303) 987-8000
Indirizzo
12100 W 6TH AVE, LAKEWOOD
Compare MLAB vs COHR, KEYS, GRMN, TDY, MKSI
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MLAB
Mesa Laboratories Inc
|
97.50 | 538.68M | 249.13M | 6.71M | 39.58M | 1.2076 |
|
COHR
Coherent Corp
|
282.39 | 55.25B | 6.60B | 452.58M | -538.24M | 2.0946 |
|
KEYS
Keysight Technologies Inc
|
318.67 | 54.46B | 6.09B | 1.07B | 1.36B | 6.0693 |
|
GRMN
Garmin Ltd
|
243.03 | 46.87B | 7.46B | 1.74B | 1.45B | 8.9685 |
|
TDY
Teledyne Technologies Inc
|
655.35 | 30.36B | 6.22B | 933.70M | 1.05B | 19.76 |
|
MKSI
Mks Inc
|
329.18 | 22.23B | 4.07B | 328.00M | 380.00M | 4.7842 |
Mesa Laboratories Inc Stock (MLAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-07 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Underweight |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-10-02 | Iniziato | JP Morgan | Neutral |
| 2019-12-04 | Iniziato | Jefferies | Buy |
| 2019-08-26 | Iniziato | Evercore ISI | Outperform |
| 2016-06-10 | Downgrade | Sidoti | Buy → Neutral |
Mostra tutto
Mesa Laboratories Inc Borsa (MLAB) Ultime notizie
TradingKey - TradingKey
MLAB|Mesa Laboratories Inc|Price:97.500|Chg%:-3.450 - TradingKey
MLAB|Mesa Laboratories Inc|Price:97.700|Chg%:-3.250 - TradingKey
Mesa Laboratories, Inc. Revenue Breakdown – NASDAQ:MLAB - TradingView
Mesa Laboratories Inc (MLAB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mesa Laboratories (MLAB) Q4 2026 earnings summary - Quartr
MESA LABORATORIES INC /CO/ ($MLAB) Former CEO and President 2026 Pay Revealed - Quiver Quantitative
Mesa Laboratories announces annual shareholder meeting - Bitget
Mesa Laboratories (MLAB) Proxy Filing Summary - Quartr
Mesa Laboratories (MLAB) Q1 2025 earnings summary - Quartr
Mesa Laboratories (MLAB) Q2 2025 earnings summary - Quartr
Mesa Laboratories (MLAB) Q3 2026 earnings summary - Quartr
Mesa Laboratories (MLAB) Q2 2026 earnings summary - Quartr
Inventory turnover of Mesa Laboratories, Inc. – GETTEX:MLI - TradingView
Long Path (MLAB) holds 8.6% of Mesa Laboratories, 477,126 shares - Stock Titan
Mesa Laboratories And 2 Other Companies That May Be Priced Below Their Estimated Value - simplywall.st
Mesa Laboratories focuses on reliable measurement solutions for regulated industries - Ad-hoc-news.de
Mesa Labs Declares Quarterly Dividend, Payable on September 15, 2026 - marketscreener.com
Mesa Labs declares $0.16 quarterly dividend payable Sept. 15 - Investing.com
Mesa Labs declares $0.16 quarterly dividend payable Sept. 15 By Investing.com - Investing.com Nigeria
Mesa Laboratories Declares Regular Quarterly Dividend of $0.16 per Share - Quiver Quantitative
MESA LABS DECLARES QUARTERLY DIVIDEND - GlobeNewswire
MLABMesa Laboratories Inc Latest SEC Filings - Finviz
Mesa Laboratories (MLAB) Rises 1.1% as Shares Rebound From Key Support LevelEarnings Miss Risk - dars.gov.et
MLAB Stock Price and Chart — NASDAQ:MLAB - TradingView
Mesa Laboratories (MLAB) Declines 3.07% as Shares Approach Key Support LevelZigzag Correction - dars.gov.et
Mesa Laboratories Inc. (MLAB) Q1 2026 Earnings: Significant EPS Miss Sends Shares LowerRevenue Per Share - dars.gov.et
Enterprise value to EBITDA forward of Mesa Laboratories, Inc. – NASDAQ:MLAB - TradingView
Price to book forward of Mesa Laboratories, Inc. – NASDAQ:MLAB - TradingView
Enterprise value to EBIT forward of Mesa Laboratories, Inc. – NASDAQ:MLAB - TradingView
Price to sales forward of Mesa Laboratories, Inc. – MUN:MLI - TradingView
Enterprise value to EBIT forward of Mesa Laboratories, Inc. – MUN:MLI - TradingView
Enterprise value to revenue forward of Mesa Laboratories, Inc. – NASDAQ:MLAB - TradingView
Price to earnings forward of Mesa Laboratories, Inc. – NASDAQ:MLAB - TradingView
Price to earnings forward of Mesa Laboratories, Inc. – MUN:MLI - TradingView
Mesa Laboratories, Inc. Actuals & Estimates (NASDAQ:MLAB) - TradingView
MLAB Forecast — Price Target — Prediction for 2027 - TradingView
Mesa Laboratories Inc. (MLAB) Climbs 3.92%: Resistance Test LoomsSystematic Flow - dars.gov.et
Mesa Labs CFO John Sakys sells $253k in company stock - Investing.com UK
Mesa Labs SVP Brian Archbold sells $225k in stock after RSU conversion By Investing.com - Investing.com South Africa
Mesa Labs SVP Brian Archbold sells $225k in stock after RSU conversion - Investing.com UK
Mesa Labs CFO John Sakys sells $253k in company stock By Investing.com - Investing.com India
Mesa Labs CAO Crennen sells $39,559 in MLAB shares - Investing.com UK
Mesa Labs CAO Crennen sells $39,559 in MLAB shares By Investing.com - Investing.com South Africa
Mesa Laboratories (MLAB) CAO reports RSU vesting and 442-share tax sale - Stock Titan
Form 4 Mesa Laboratories Inc For: 23 June By Investing.com - Investing.com Canada
Mesa Laboratories (MLAB) SVP exercises RSUs and sells 2,516 shares - Stock Titan
Mesa Laboratories (MLAB) CFO reports grants, RSU conversions and tax-cover share sale - Stock Titan
Mesa Laboratories Inc Azioni (MLAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mesa Laboratories Inc Azioni (MLAB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Crennen Lyndsey Elizabeth | CAO |
Jun 22 '26 |
Sale |
89.50 |
442 |
39,560 |
2,020 |
| Archbold Brian David | SVP Operations |
Jun 18 '26 |
Option Exercise |
95.10 |
3,324 |
316,112 |
7,034 |
| Archbold Brian David | SVP Operations |
Jun 22 '26 |
Sale |
89.50 |
2,516 |
225,187 |
6,377 |
| Sakys John | CFO |
Jun 18 '26 |
Option Exercise |
95.10 |
3,792 |
360,619 |
20,330 |
| Sakys John | CFO |
Jun 22 '26 |
Sale |
89.50 |
2,827 |
253,022 |
19,785 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):